Effectiveness of Care: HIV/AIDS

2009 National Healthcare Quality and Disparities Reports

The National Healthcare Quality Report (NHQR) is a comprehensive national overview of quality of health care in the United States. It is organized around four dimensions of quality of care: effectiveness, patient safety, timeliness, and patient centeredness.


Testing for HIV Infection
Women ages 15-44 who completed a pregnancy in the last 12 months and received an HIV test as part of prenatal care
People ages 15-44 who ever received an HIV test outside of blood donation
People ages 15-44 with any HIV risk behaviors in the last 12 months who received an HIV test outside of blood donation in the last 12 months

Management of HIV/AIDS
New AIDS cases per 100,000 population age 13 and over
Adult patients with HIV and CD4 count ≤200 who received Pneumocystis pneumonia (PCP) prophylaxis
Adult patients with HIV and CD4 count <50 who received Mycobacterium avium complex (MAC) prophylaxis
HIV infection deaths per 100,000 population
 


Testing for HIV Infection

Measure Title

Women ages 15-44 who completed a pregnancy in the last 12 months and received an HIV test as part of prenatal care.

Measure Source

Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Survey of Family Growth (NSFG).

Table

Data table will not be presented this year.

Data Source

CDC, NCHS, NSFG.

Denominator

Women ages 15-44 who completed a pregnancy in the last 12 months.

Numerator

Subset of the denominator who had an HIV test as part of prenatal care.

Top of Page


Testing for HIV Infection

Measure Title

People ages 15-44 who ever received an HIV test outside of blood donation.

Measure Source

Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Survey of Family Growth (NSFG).

Table

Data table will not be presented this year.

Data Source

CDC, NCHS, NSFG.

Denominator

U.S. civilian noninstitutionalized adults ages 15-44.

Numerator

Subset of the denominator who ever had an HIV test outside of blood donation.

Top of Page


Testing for HIV Infection

Measure Title

People ages 15-44 with any HIV risk behaviors in the last 12 months who received an HIV test outside of blood donation in the last 12 months.

Measure Source

Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Survey of Family Growth (NSFG).

Table

Data table will not be presented this year.

Data Source

CDC, NCHS, NSFG.

Denominator

People ages 15-44 who reported risk behaviors for HIV in the past 12 months.

Numerator

Subset of the denominator who reported ever having an HIV test outside of blood donation.

Top of Page


Management of HIV/AIDS

Measure Title

New AIDS cases per 100,000 population age 13 and over.

Measure Source

Healthy People 2010.

Tables

5_2_1.1 New AIDS cases per 100,000 population age 13 and over, United States, 2000 and 2007.

5_2_1.2 New AIDS cases per 100,000 population age 13 and over, United States, 2007, by:

  • Ethnicity.

Data Source

Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), National HIV/AIDS Surveillance System (HIV/AIDS-SS).

Denominator

U.S. population age 13 and over.

Numerator

Number of reported new AIDS cases among adolescents and adults age 13 and over.

Comments

The AIDS case definition used by the HIV/AIDS Reporting System for an AIDS case is provided by CDC. Data are adjusted for reporting delay. Data exclude cases from U.S. dependencies, possessions, and independent nations in free association with the United States.

CDC Adult HIV/AIDS Confidential Case Report, Form 50.42A, Rev. 7/93.

This measure is referred to as measure 13-1 in Healthy People 2010 documentation.

Top of Page


Management of HIV/AIDS

Measure Title

Adult patients with HIV and CD4 count ≤200 who received Pneumocystis pneumonia (PCP) prophylaxis.

Measure Source

HIV Research Network (HIVRN).

Tables

5_2_2.1 Adult patients with HIV and CD4 count ≤200 who received Pneumocystis pneumonia (PCP) prophylaxis, United States, 2004 and 2006.

5_2_2.2 Adult patients with HIV and CD4 count ≤200 who received Pneumocystis pneumonia (PCP) prophylaxis, United States, 2006, by:

  • Race/ethnicity.

Data Source

HIV Research Network, sponsored by multiple Federal agencies: AHRQ, Substance Abuse and Mental Health Services Administration, Health Resources and Services Administration, and National Institutes of Health Office of AIDS Research (HIVRN).

Denominator

Patients diagnosed with HIV with CD4 counts ≤200 cells/mm.

Numerator

Subset of denominator who received PCP prophylactic therapy.

Comments

The taxonomy of the PCP organism has been changed; Pneumocystis jiroveci refers to the distinct species that infects humans. The abbreviation PCP is still used to designate Pneumocystis pneumonia.

For further information, refer to Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004;53 (No. RR-15). Available from the CDC Website at http://www.cdc.gov/mmwr/.

Top of Page


Management of HIV/AIDS

Measure Title

Adult patients with HIV and CD4 count <50 who received Mycobacterium avium complex (MAC) prophylaxis.

Measure Source

The HIV Research Network.

Tables

5_2_3.1 Adult patients with HIV and CD4 count ≤50 who received Mycobacterium avium complex (MAC) prophylaxis, United States, 2004 and 2006.

5_2_3.2 Adult patients with HIV and CD4 count ≤50 who received Mycobacterium avium complex (MAC) prophylaxis, United States, 2006, by:

  • Race/ethnicity.

Data Source

HIV Research Network, sponsored by multiple Federal agencies: AHRQ, Substance Abuse and Mental Health Services Administration, Health Resources and Services Administration, and National Institutes of Health Office of AIDS Research (HIVRN).

Denominator

Patients diagnosed with HIV with CD4 counts ≤50 cells/mm.

Numerator

Subset of denominator who received MAC prophylactic therapy.

Comments

For further information, refer to Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004;53 (No. RR-15). Available from the CDC Website at http://www.cdc.gov/mmwr/.

Top of Page


Management of HIV/AIDS

Measure Title

HIV infection deaths per 100,000 population.

Measure Source

Healthy People 2010.

National Tables

5_2_4.1 HIV infection deaths per 100,000 population, United States, 1999 and 2006.

5_2_4.2 HIV infection deaths per 100,000 population, United States, 2006, by:

  • Race.
  • Ethnicity.

National Data Source

Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Vital Statistics System — Mortality (NVSS-M).

National Denominator

U.S. resident population.

National Numerator

Number of deaths due to HIV infection (ICD-10-CM codes B20-B24).

State Tables

5_2_4.3 HIV infection deaths per 100,000 population, by State, 1999 and 2006.

State Data Source

CDC, NCHS, NVSS-M.

State Denominator

Population, by State.

State Numerator

Same as National.

Comments

Data are age adjusted to the 2000 standard population. Age-adjusted rates are weighted sums of age-specific rates. Resident death data are based on information from death certificates filed in the 50 States and the District of Columbia.

This measure is referred to as measure 13-14 in Healthy People 2010 documentation.

 

Current as of March 2010
Internet Citation: Effectiveness of Care: HIV/AIDS: 2009 National Healthcare Quality and Disparities Reports. March 2010. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/nhqrdr/nhqrdr09/measurespec/HIV_AIDS.html